Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration
Top Cited Papers
- 1 November 2006
- journal article
- guideline
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 59 (11) , 1134-1149
- https://doi.org/10.1016/j.jclinepi.2005.12.020
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Acupuncture and Chinese herbal medicine in the treatment of patients with seasonal allergic rhinitis: a randomized‐controlled clinical trialAllergy, 2004
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Analysis of phenolic compounds and radical scavenging activity of Echinacea spp.Journal of Pharmaceutical and Biomedical Analysis, 2004
- Analysis of Catechin Content of Commercial Green Tea ProductsJournal of Herbal Pharmacotherapy, 2003
- Herb-Drug Interactions and Confounding in Clinical TrialsJournal of Herbal Pharmacotherapy, 2002
- Herbal therapy for treating rheumatoid arthritisPublished by Wiley ,2000
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTIONThe Lancet, 1988